公司資料
Precipio Diagnostics 股價、新聞與催化劑
- 股票代碼:
- PRPO
- 交易所:
- NASDAQ
- 產業:
- MedTech
- 所在地:
- United States
股票表現
23.90 USD (+1.70%)
收盤價
最後更新: 2026年8月17日
40.2M USD
市值
股價為何變動
The latest company update was “Precipio Announces Q2-2026 Financial Results”. PRPO changed 1.70% and closed at $23.90 on Aug 17, 2026, indicating a relatively limited closing-price reaction to this earnings update.
公司概覽
Cancer Diagnostics Company
Precipio is a specialty cancer diagnostics company focused on reducing misdiagnosis in hematologic malignancies. It develops testing approaches intended to improve diagnostic accuracy for physicians, laboratories, and patients.
Integrated Clinical Laboratory
The company operates its own clinical laboratory, where it develops, validates, and uses diagnostic technologies in routine patient testing. This internal laboratory infrastructure provides a setting for generating clinical evidence and refining new assays before broader commercialization.
Products and Services Model
Precipio combines laboratory testing services with proprietary diagnostic products marketed to laboratories. This model allows the company to serve physicians directly while also distributing technologies that other laboratories can incorporate into their workflows.
未來催化劑
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。